← Back to Intel
Insider ActivityTLX
Behrenbruch Christian, MD & Group CEO, Director at Telix Pharmaceuticals Ltd, bought $500K of TLX
Updated Jun 15, 2026
Behrenbruch Christian
MD & Group CEO, Director
Telix Pharmaceuticals Ltd ·
$TLX
Transaction Details
| Insider | Behrenbruch Christian |
|---|---|
| Title | MD & Group CEO, Director |
| Company | Telix Pharmaceuticals Ltd |
| Ticker | TLX |
| Transaction Type | Purchase |
| Transaction Date | 2026-04-28 |
| Shares Traded | 34,500 |
| Price Per Share | $14.48 |
| Total Value | $500K |
| Filed Date | 2026-05-06 |
| Accession Number | 0001628280-26-031608 |
Ownership Context
| Shares Owned After Transaction | 20,709,500 |
|---|---|
| Ownership Type | Indirect |
SEC Filing
Accession: 0001628280-26-031608
Other Insider Trades — TLX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Behrenbruch Christian | MD & Group CEO, Director | bought | $497K | 2026-04-29 |
| Smith Darren Charlton | Group Chief Financial Officer | traded | — | 2026-03-29 |
Other Trades by Behrenbruch Christian
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| TLX | Telix Pharmaceuticals Ltd | bought | $497K | 2026-04-29 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for TLX — Telix Pharmaceuticals Ltd →
Track TLX insider activity in real time on The Wire →
Get alerts when Behrenbruch Christian files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 15, 2026 at 07:15 UTC